We are live on ! Find out more
TAPR

iPath Inverse US Treasury Composite ETN

Delisted

TAPR was delisted on the 8th of December, 2020.

1 hedge funds and large institutions have $12K invested in iPath Inverse US Treasury Composite ETN in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $11K → $12K (+$1K)

0% more funds holding

Funds holding: 11 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$3.15K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$12K -$3.15K -6 -23%

TAPR Hedge Fund Activity: Q2 2015 in Review

1 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse US Treasury Composite ETN (TAPR) for Q2 2015, worth a combined $12K — up 9.1% from $11K a quarter earlier.

Fund positioning in TAPR was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Tower Research Capital (TRC), cutting an estimated $3.15K.

  • 1 institutional investor held iPath Inverse US Treasury Composite ETN (TAPR) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $12K of iPath Inverse US Treasury Composite ETN stock for Q2 2015, up 9.1% quarter-over-quarter.
  • 0 funds opened new iPath Inverse US Treasury Composite ETN positions in Q2 2015 and 0 closed out.
  • The largest iPath Inverse US Treasury Composite ETN seller in Q2 2015 was Tower Research Capital (TRC), an estimated $3.15K sold.

Based on aggregated 13F filings for Q2 2015.